Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

The final data set won't contain anything else. They just released data on 123 patients. Do you know why they did that instead of 73? Because clearly they found no effect at 73 patients so they analyzed more in order to increase the statistical power to try and find a trend. That is concerning. That is why I think this is dropping. It's a bit like data mining. You really don't want to see a company need to look furhter to find the change they need to prevent the stock from dropping ... The only glimmer of hope is that the PHASE 3 will still go ahead and amass enough patients to turn a trend into statistical significance. The "final" data set only will contain an extra 20 patients...